The Centers for Medicare & Medicaid Services yesterday released COVID-19 infection control guidance for Programs of All-Inclusive Care for the Elderly (PACE) organizations, noting that there may be circumstances where a PACE organization may need to implement strategies that do not fully comply with CMS PACE program requirements. “CMS will take those situations into consideration when conducting monitoring or oversight activities.” For example, it said PACE organizations “may use remote technology as appropriate, including for scheduled and unscheduled participant assessments, care planning, monitoring, communication, and other related activities that would normally occur on an in-person basis.” They also may provide home or mail delivery of Part D drugs and waive prior authorization requirements for Part D drugs used to treat or prevent COVID-19, when such drugs are identified.

Related News Articles

Headline
The Food and Drug Administration today released two guidance documents; one related to low-risk wellness products (including certain wearable devices) and the…
Headline
The Centers for Disease Control and Prevention announced Dec. 16 that it adopted individual-based decision-making for parents deciding whether to give the…
Headline
The Centers for Disease Control and Prevention Dec. 11 released a report that found last year’s version of the COVID-19 vaccine was 76% effective in preventing…
Headline
The Centers for Disease Control and Prevention issued an advisory Dec. 3 on an outbreak of Marburg virus in Ethiopia. The agency said a risk of spread to the U…
Headline
The AHA provided recommendations to the Food and Drug Administration Dec. 1 in response to a request for information on the measurement and evaluation of…
Headline
The Food and Drug Administration has identified a Class I recall of Baxter Life2000 Ventilation Systems due to a cybersecurity issue discovered through…